Citations 0
September 2005

Etanercept and the Treatment of Multicentric Reticulohistiocytosis

Author Affiliations

Copyright 2005 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2005

Arch Dermatol. 2005;141(9):1167-1168. doi:10.1001/archderm.141.9.1167-b

In their recent article, Kovach et al1 reported successful treatment of multicentric reticulohistiocytosis (MR) with etanercept. Their patient was treated with a 25-mg subcutaneous injection of etanercept biweekly, 20 mg of prednisone daily, and 15 mg of methotrexate by mouth weekly and showed improvement in skin and joint symptoms within 1 month. We report a less successful application of etanercept in the treatment of MR.

First Page Preview View Large
First page PDF preview
First page PDF preview